Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22965590 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
2 Completed
Has Results
A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Sham injection
3 Recruiting Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept

Study has passed its completion date and status has not been verified in more than two years.